Humans2,602 adults6 monthsCohort study

Effectiveness and Safety of Fixed-Dose Combination Metformin and Empagliflozin in Type 2 Diabetes: A Prospective, Multicenter, Real-World Study From China

Graphical abstract from Journal of Diabetes
Open the figure at full size
Graphical abstractKe et al. · CC BY

Journal of Diabetes

Abstract

Background This study assessed the real-world effectiveness and safety of a fixed-dose combination (FDC) of metformin and empagliflozin in Chinese patients with type 2 diabetes mellitus (T2DM).

The paper